Media about us
-
26 July 2013
Reuters
The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company (a subsidiary of RUSNANO and Domain Associates) have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region.
-
26 July 2013
NovaMedica Inks Pact to Build $85 Million Facility, 100 New Jobs Will be Created
BioSpace
The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company (a subsidiary of RUSNANO and Domain Associates) have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region.
-
05 June 2013
BioForward
S.Fyodorov Eye Microsurgery Complex Federal State Institution and NovaMedica (a pharmaceutical subsidiary of RUSNANO and Domain Associates) have signed an agreement that covers cooperation on localization of innovative ophthalmic products and technologies sourced from around the globe to be developed and produced in Russia.
-
05 June 2013
S.Fyodorov Eye Microsurgery Complex and NovaMedica Have Signed a Cooperation Agreement
HeraldOnline.com
S.Fyodorov Eye Microsurgery Complex Federal State Institution and NovaMedica (a pharmaceutical subsidiary of RUSNANO and Domain Associates) have signed an agreement that covers cooperation on localization of innovative ophthalmic products and technologies sourced from around the globe to be developed and produced in Russia.
-
05 June 2013
BayBio
S.Fyodorov Eye Microsurgery Complex Federal State Institution and NovaMedica (a pharmaceutical subsidiary of RUSNANO and Domain Associates) have signed an agreement that covers cooperation on localization of innovative ophthalmic products and technologies sourced from around the globe to be developed and produced in Russia.
-
28 May 2013
Prescription drugs with nanotechnology. Americans to build a pharmaceutical plant in Kaluga
Yulia Kostina, Smart News
NovaMedica, a joint venture of Domain Associates and RusnanoMedInvest, will complement the pharmaceutical cluster in Kaluga region. A projected plant will be specializing in the manufacturing of therapeutics and medicines for kids. The plant’s capacity is 200 Mio tablets and 5 Mio ampules a year.
-
27 May 2013
Maria Dranishnikova, Vedomosti
“NovaMedica, LLC plans to build a plant at the site of Kaluga pharmaceutical cluster”, - told Vladimir Gurdus, Team Drive (project managing company) member of the Board while present at the Russian pharmaceutical forum, organized by Adam Smith Institute.
-
29 March 2013
Russian investment vehicle sets sights on innovative drugs
Eugene Gerden, Chemistry World
Russian state-owned nanotechnology giant Rusnano is hoping to break into the pharmaceutical sector with sizeable investments in firms seeking to produce innovative drugs. Rusnano has been ploughing hundreds of millions of dollars into pioneering pharma companies with the aim of growing Russia’s domestic drug production, and making a tidy return by licensing drugs to foreign partners.
-
04 February 2013
Russia is becoming a player in global biopharma
Business New Europe (bne)
A biotechnology revolution is gathering steam in Russia, spurred by state investment programs, a host of cross-border partnerships and a domestic market that international investors find highly attractive. The government is modernizing a decaying healthcare system by building new hospitals and introducing innovative technologies.
-
20 December 2012
Russia fund in consortium to back U.S. pharma firms
Megan Davies, Reuters
Russian state technology firm Rusnano, alongside a group of investors, is investing $93 million in three U.S.-based pharmaceutical firms to develop drugs to treat illnesses such as epilepsy, the investors said on Wednesday.
All Portfolio
MEDIA CENTER
-
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.